Mind you no-one has still answer why these 80 non-directors employee were still on an average of $150K even before the re-allocation.....are they all world class professor scientists/marketing experts/receptionist/accountants/manufacturers/PA.
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-182
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.77 |
Change
-0.230(1.92%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.57 | $11.79 | $11.54 | $22.42K | 1.919K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1365 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.84 | 160 | 3 |
View Market Depth
| Last trade - 12.39pm 10/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |